guanabenz has been researched along with Protein Folding Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabral-Miranda, F; Duran-Aniotz, C; Hetz, C; Martínez, G; Vivar, JP | 1 |
| Antonini, G; Bella, ED; Bella, V; Borghero, G; Capasso, M; Caponnetto, C; Chiò, A; Corbo, M; Eleopra, R; Filosto, M; Giannini, F; Granieri, E; Lauria, G; Lunetta, C; Mandrioli, J; Mazzini, L; Messina, S; Monsurrò, MR; Mora, G; Riva, N; Rizzi, R; Siciliano, G; Silani, V; Simone, I; Sorarù, G; Tramacere, I; Volanti, P | 1 |
| Barry, N; Bertolotti, A; D'Antonio, M; Das, I; Krzyzosiak, A; Schneider, K; Sigurdardottir, A; Wrabetz, L | 1 |
| Crunkhorn, S | 1 |
1 review(s) available for guanabenz and Protein Folding Diseases
| Article | Year |
|---|---|
Endoplasmic reticulum proteostasis impairment in aging.
Topics: Adenine; Aging; Animals; Brain; Caenorhabditis elegans; Drosophila melanogaster; Endoplasmic Reticulum Stress; Guanabenz; Humans; Indoles; Neurodegenerative Diseases; Neurons; Protective Agents; Proteome; Proteostasis; Proteostasis Deficiencies; Saccharomyces cerevisiae; Unfolded Protein Response | 2017 |
1 trial(s) available for guanabenz and Protein Folding Diseases
| Article | Year |
|---|---|
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial).
Topics: Adrenergic alpha-2 Receptor Agonists; Age of Onset; Amyotrophic Lateral Sclerosis; Disease Progression; Double-Blind Method; Endoplasmic Reticulum Stress; Guanabenz; Humans; Italy; Medical Futility; Neuroprotective Agents; Proteostasis Deficiencies | 2017 |
2 other study(ies) available for guanabenz and Protein Folding Diseases
| Article | Year |
|---|---|
Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit.
Topics: Amyotrophic Lateral Sclerosis; Animals; Cells, Cultured; Charcot-Marie-Tooth Disease; Disease Models, Animal; Endoplasmic Reticulum Stress; Enzyme Inhibitors; Guanabenz; HeLa Cells; Humans; Mice; Mice, Transgenic; Molecular Targeted Therapy; Phosphorylation; Protein Folding; Protein Phosphatase 1; Proteostasis Deficiencies; Signal Transduction | 2015 |
Neurodegenerative disease: Phosphatase inhibitor prevents protein-misfolding diseases.
Topics: Animals; Enzyme Inhibitors; Guanabenz; Humans; Protein Phosphatase 1; Proteostasis Deficiencies | 2015 |